Synopsys President & CEO Sassine Ghazi Exercises Options and Sells $5.47M Under 10b5-1 Plan

Insider Trading Analysis: Synopsys Inc (SNPS)

Executive Summary

On September 15, 2026, Sassine Ghazi, President and Chief Executive Officer of Synopsys Inc ($SNPS), executed a pre-planned option exercise and stock sale under a Rule 10b5-1 trading plan adopted on September 19, 2025.

Key Transaction Details

• Derivative Exercise: Exercised non-qualified stock options to acquire 14,604 shares of Common Stock at an exercise price of $135.88 per share (expiring December 12, 2026).
• Open-Market Disposition: Sold all 14,604 shares at a weighted average price of $374.8756 (transaction prices ranging from $371.995 to $379.990).
• Total Gross Proceeds: $5,474,683.26
• Net Cash Flow (pre-tax): Approximately $3,489,392.52 after accounting for the option exercise cost of $1,985,290.74.
• Post-Transaction Holdings: Ghazi retains 76,865 shares directly.

Strategic & Market Context

• Trading Plan (10b5-1): The transaction was executed strictly according to a predetermined 10b5-1 trading plan established in September 2025.
• Option Expiration: The underlying options were approaching their December 2026 expiration date, making this a routine exercise-and-sell transaction.
• Significance Assessment: Low. The transaction does not reflect discretionary market timing or a fundamental change in executive sentiment, but rather standard executive compensation monetization.